Samuel B Pegram, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3316 Williams Dr Ste 150, Georgetown, TX 78628 Phone: 512-244-4272 Fax: 512-244-2895 |
Dr. Shalene Badhan, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3201 S Austin Ave Ste 325, Georgetown, TX 78626 Phone: 507-751-2717 Fax: 512-713-0844 |
News Archive
State and Federal Communications, Inc. - which provides government affairs compliance information and consulting - is sharing a report on how states are responding to the Supreme Court's landmark decision in Citizens United v. Federal Election Commission.
According to the latest research, a drug derived from plant extracts could wipe out tumors in a single treatment with minimal side effects. Scientists have turned a chemical found in crocuses into a ‘smart bomb' that targets cancerous tumors. The advantage is that healthy tissue is unharmed, reducing the odds of debilitating side effects. And unlike other side effect-free drugs, it is able to kill off more than one type of the disease, including breast, prostate, lung and bowel cancer. Potentially, all solid tumours could be vulnerable to drugs developed this way, meaning it could be used against all but blood cancers.
Recruitment of leukocytes is a hallmark of stent thrombosis, according to results from the PRESTIGE study presented today at ESC Congress and published in European Heart Journal. The findings suggest that immune cell mediated thrombotic processes may be a realistic target for novel therapies to prevent stent thrombosis.
An Indiana University scientist studying human bone growth has received a $2.6 million grant from the U.S. Department of Defense to study a chemical compound with potential to fight osteoporosis and accelerate broken bone healing.
Advantech, a leading provider of industrial computing solutions, is pleased to announce its POC-624 24" medical-grade point-of-care terminal (POC) designed for diverse healthcare applications. Featuring an 8th gen Intel® Core™ i5/i7-8665UE processor, POC-624 is a high-performance, ultra-thin terminal that enables improved operational efficiency in hospitals, clinics, and care homes. Compliant with IEC 60601 safety standards for medical devices, the POC-624 terminal is user friendly and offers a reduced time-to-market with its compliance with relevant healthcare regulations.
› Verified 4 days ago